Home About Us Products Clinical Trials Media Career Contact Us
PRODUCTS > INFINNIUM Supralimus-Core | Supralimus | Coronnium | Infinnium | Matrix Instructions for use Download Brochure Features of Infinnium®: The Infinnium®-Paclitaxel Eluting Coronary Stent System contains biodegradable, hemocompatible polymers as a drug delivery vehicle with therapeutic agent. The Stent is covered with drug-polymeric matrix all the way around the struts providing efficient drug release into vessel wall. Features of Infinnium® Paclitaxel Eluting Stent : • The unique design and strut locking mechanism offers excellent radial strength and minimum recoil even with thinner strut. • Smooth surface, round edges and thin struts of stent minimizes vessel injury and obliging in reduces thrombus formation incidence.                 Therapeutic Agent-Paclitaxel: • A microtubule-stabilizing drug that has been shown to inhibit smooth muscle cell migration and proliferation which contributes to neointimal hyperplasia.   • Due to lipophilic nature Paclitaxel support uniform drug distribution in the arterial cells and metabolized at very slow rates and thus have a long term effect.   • At the optimal dose of Paclitaxel incorporated in Infinnium®, it does not impede the natural healing process.   • Blocks the cell cycle between G2/M phase.   • FDA Approved drug for ovarian (1992), breast (1994), AIDS related (1997) and Lung (1998) cancers.   Surface Morphology of Infinnium® Paclitaxel Eluting Stent:         • Uniform drug and biodegradable polymers multilayer coating on stent surface. • Coating integrity maintained on stent crimping and expansion. • The drug-polymers coating thickness is 5-7µm. Preclinical: • Good degree of Endothelialization   • No cytotoxic response   • Proven In vitro and In vivo hemocompatibility                                                   Infinnium® Stent Specification: Description Infinnium® Stent Stent Material 316L Stainless Steel (SS) Stent Design Laser cut from seamless tubing in a serpentine pattern Stent Platform The CE approved Millennium Matrix® Stent Stent Strut thickness / width 0.08mm (80µ) / 0.11mm (110µ) Average Stent Foreshortening < 1% Average Recoil < 5% Average Radial Strength Resists at least 1 bar Metal to Artery Ratio (φ 3.0mm) 13.1% Drug Paclitaxel Polymers Type Biodegradable Polymers Supralimus-Core | Supralimus | Coronnium | Infinnium | Matrix         Home  |  About Us  |  Products  |  Clinical Trials  |  Media  |  Career  |  Contact Us  |  Site Map  |  Privacy Policy Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India Tel: +91-261-2521251-58 Fax: +91-261-2520252 © Copyright 2008. All rights reserved. Last Update: 2008/05/14